Basic examination on drug level analysis in hair of antiarrhythmic drug flecainide.
نویسندگان
چکیده
منابع مشابه
The antiarrhythmic drug BRL-32872.
BRL-32872 is a new antiarrhythmic drug with balanced class-III and class-IV actions as categorized by the Vaughan-Williams classification. BRL-32872 blocks the rapid component of the cardiac delayed rectifier potassium channel IK(r) (IC(50) = 28 nM) and its molecular correlate HERG ("Human-ether-a-go-go related gene," IC(50) of 19.8 nM in cell lines) at low concentrations. It also inhibits the ...
متن کاملPreparation of Hair Samples for Drug Analysis.
Toxicological hair analysis has attracted substantial attention because of its promising diagnostic power. Analysis of drugs in hair, even though widely studied since 1970, is still not standardized; many different sample preparation and analytical procedures are practiced. To obtain reliable results, hair analysis requires preparation steps that are not necessary for conventional biological sa...
متن کاملLidoflazine as an antiarrhythmic drug.
Since Schaper and his coworkers1-3 reported an excellent coronary vasodilating action of lidofiazine, a drug originally prepared in Janssen Pharmaceutica Institute, on conscious dogs with a previously implanted electromagnetic flow meter, the antianginal effect of the drug has been clinically investigated in our own and other laboratories. Its usual dose is 90 or 120mg per day. Recently, we adm...
متن کاملDrug-facilitated crimes. Evidence by hair analysis
Introduction In the last few years, considerable information about drug-facilitated crimes (rape, sexual assault, robbery, sedation of persons) has accumulated. In these situations, the victims are subjected to non-consensual acts while they are incapacitated through the effects of a drug. This impairs their ability to resist or to give consent to the act. In a typical scenario, a predator (rap...
متن کاملProphylactic Antiarrhythmic Drug Therapy in Atrial Fibrillation.
In patients with recurrent atrial fibrillation (AF), the hallmark of treatment has been the use of antiarrhythmic drugs (AADs). Goals of therapy include reduction in the frequency and duration of episodes of arrhythmia as well an emerging goal of reducing mortality and hospitalizations associated with AF. Safety and efficacy are important factors when choosing an antiarrhythmic drug for the tre...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics
سال: 1999
ISSN: 1882-8272,0388-1601
DOI: 10.3999/jscpt.30.307